Responding To Pharmaceutical Drug Serialization
In an effort to combat the world of counterfeit drugs and keep patient safety top of mind, the Federal Drug Administration enacted the Drug Supply Chain Security Act, DSCSA, a phased approach to pharmaceutical serialization.
A Phased Approach To Pharmaceutical Serialization
This phased approach brings with it deadlines to complete product tracking with the end goal being each unit of medication will be able to be traced from the point of origin to the end consumer.
Pharmaceutical manufacturers must include a unique product identifier on prescription drug packaging and cases.
This unique identifier includes the product’s lot number, expiration date, national drug code, and serial number, making it easily identifiable throughout the course of its shelf life.
In addition to making products easily trackable, pharmaceutical serialization also allows officials to better detect illegitimate products throughout the supply chain[1].
Approach
For MD Logistics, our approach to pharmaceutical serialization began in 2008 when we started a conversation with one of our customers.
Our conversation had grown more in-depth to the point where we were building out a plan based on their needs and the requirements of the Federal Drug Administration enacted the Drug Supply Chain Security Act, the DSCSA legislation.
In addition to needing to document where every unit was manufactured, we also needed to capture all serial numbers down to the unit on their way into our building.
We were given all serial numbers in a unit, inner pack, case, pallet hierarchy from our customer and had to ensure they were received into our warehouse management system (WMS), JDA/Red Prairie (now Blue Yonder).
Tracking unit movement from the manufacturer through to the end consumer is a huge element of the DSCSA legislation. Through our integration, we needed to make sure our WMS was tracking this internally and then also pushing that data out to our customers’ third-party solution which was tracking the entire life of the product. We did this by building serialized messages to communicate to our customers’ system what product had been received into our warehouse and subsequently shipped out.
To conceptualize what we needed to do as a 3PL provider, my team and I worked alongside our customers to develop a test environment that included all the elements that we were expected to carry out in our solution. Through this test environment, we were able to collaborate with our customers, identify potential bottlenecks, and troubleshoot issues that arose prior to implementation. Once testing was complete, we began capturing serial numbers in our live WMS environment.
Expectation vs. Reality
Our early research indicated there wasn’t a provider who had implemented a solution to this magnitude before. We realized that industry benchmarks and procedures were not available for reference, and we would need to rely on our own testing experience to develop serialized processes. While it was easy to conceptualize what we wanted this process to look like, the actual reality of the situation is that once we took our pharmaceutical serialization solution ‘live’, there was an immediate need for additional training and personnel. We had to hire additional team members just to analyze the sheer influx of data that we now were tasked with handling.
We had to upgrade our IT systems in order to handle the influx of information that was entering our WMS with every delivery to our warehouse. We also had to upgrade from a paper to a digital auditing system. Additionally, our operations team had to learn to use new RF equipment.
Challenges & Learning Experiences
With a project of this magnitude comes a great deal of challenges and learning experiences. We ran into challenges as it related to our existing IT systems and operations processes. In addition to the system upgrades, we had to make several updates to the technology we used on the warehouse floor. We added printers and RF guns to make our processes as efficient as possible to ensure the speed at which orders left the building went unaffected. The emphasis that we placed on inventory control grew exponentially.
Through all the challenges came great learning experiences. Our team learned to adapt and remain nimble throughout all phases of the project. Our IT teams had to adapt to the changes that needed to be made to existing systems and code within our WMS system.
Our operations teams had to undergo training to learn the proper way to receive the serialized products into the warehouse and the WMS. For many of our warehouse associates, they had to learn how to use new technology. In addition to learning and adapting to a new ‘normal’, our entire operations team worked together to make sure all customer orders left our facility in a timely manner.
A project of this magnitude is not accomplished without the entire company coming together to lend their expertise and a helping hand where needed. Within the company, there were a number of individuals who put in long hours during the week and on the weekends to make sure the transition to a serialized solution was as smooth as possible and our customers remained unaffected.
Conclusion
The MD Logistics Team rose to the challenge of implementing a new solution for our customer, a solution on which few 3PL’s had embarked previously. As a result of our hard work, our customer is now not only compliant with the November 2018 pharmaceutical serialization requirements, they are now ready for the package-level tracing requirements expected to be implemented in 2023[1]. Throughout this whole process, my admiration of our team has grown. Together we have much to be proud of.
References
[2] “Drug Supply Chain Security Act: Overview of Product Tracing Requirements” (PDF).
MD Logistics Life Sciences & Pharmaceuticals
MD Logistics designs customized supply-chain solutions for global distribution of trade, sample, and clinical specialty products. Our facilities are fully licensed and accredited, maintaining cGMP and VAWD standards, enabling us to provide compliant cold chain storage for finished and WIP products. We deliver these standards through the utilization of tier-one WMS and strategically located state-of-the-art facilities. We offer full integration with our customers' ERP software and support electronic data interchange for order management and reporting. Most critical to operational success, our dedicated and experienced pharmaceutical team stands behind our services to ensure the utmost product quality and maximum customer satisfaction.
Value-Added Services:
- Licensed Pharmaceutical Wholesaler
- Multi-site Redundant Facilities for Disaster Recovery
- Dedicated Call Center
- Control Room Temperature (CRT) and Refrigerated Storage (2 to 8°C)
- State-of-the-Art Digital Security Systems and Temperature Monitoring
Packaging Services for Life Sciences & Pharmaceuticals
MDL packaging services provide high-speed, high-volume, production without client capital investment. We specialize in providing hand-packing, kitting, and labeling for pharmaceuticals and pharmaceutical devices.
Related White Papers
Getting Serious About Serialization, The Drug Quality, And Security Act
This white paper will discuss why serialization is a necessity for the integrity and visibility of pharmaceutical supply chains as well as three traits that are essential to successful serialization implementation. Download Now!
Safely Transporting Cold Chain Pharmaceutical Product
This white paper will discuss the components to consider when defining a transportation solution for your pharmaceutical supply chain and how incorporating a third party into your solution will pay dividends. Download Now!
The Legislation that is Shaping the U.S. Pharmaceutical Supply Chains
On Nov. 27, 2013, President Obama signed the Drug Quality and Security Act into law, effectively setting the framework of what would become a nationwide initiative toward wide-scale pharmaceutical serialization. Download Now!
Extending the Life Sciences and Pharmaceuticals Supply Chain
A comprehensive analysis of how value-added services are revolutionizing an industry. Download Now!
Controlling Temperature in Pharmaceutical Supply Chains
A comprehensive analysis of temperature control processes as essential components of an efficient quality control process. Download Now!
More Resources from MD Logistics
Read the Article: Bringing Foreign Trade Zone Services to Bear for Pharmaceutical Customers
Article Topics
MD Logistics News & Resources
Flexing Labor Practices to Respond to Supply Chain Disruptions Creating Mutually Successful 3PL Partnerships through Systems Integration Supply Chain Re-Engineering: How Does The Supply Chain Move On From A Global Pandemic? Transportation Management Integration Grows into Innovative Partnership for Leading 3PL Provider The Ecommerce, Mcommerce and Omnichannel Effect Returns in the Retail Supply Chain with a Specific Focus on Ecommerce Responding To Pharmaceutical Drug Serialization More MD LogisticsLatest in Supply Chain
A Look at Baltimore’s Key Bridge Collapse—One Month Later European Parliament Passes New Law Requiring Supply Chain Accountability Baltimore Continues Bridge Recovery With Opening of New Channel How Shippers Can Prep for Hurricane Season Apple Accused of Multiple Human Rights Violations South Korea Finally Overtakes China in Goods Exported to U.S. UPS Struggles in First Quarter With Steep Earnings Decline More Supply Chain
